The global foot care products market size was valued at USD 3.64 billion in 2023 and is expected to be worth  USD 3.84 billion in 2024. The market is projected to reach  USD 6.28 billion by 2032, recording a CAGR of 6.36% during the forecast period.

Products that support preserving the best possible health of the feet are referred to as foot care products. Due to factors including increased sports involvement and the adoption of an active lifestyle, the prevalence of foot-related conditions is rising alarmingly worldwide. The need for foot care products is growing quickly since these situations can make people more likely to get hurt and get fungal diseases.

Fortune Business Insights™ displays this information in a report titled, "Foot Care Products Market, 2024-2032."

Top Key Player in the Foot Care Products Market:

• Reckitt Benckiser Group Plc (U.K.)
• Pedifix Inc. (U.S.)
• Medi GmbH & Co. KG (Germany)
• Johnson & Johnson Services Inc. (U.S.)
• Revlon Inc. (U.S.)
• Merck & Co. Inc. (U.S.)
• MAGHAM Inc. (Canada)
• HoMedics USA LLC (U.S.)
• Aetrex Worldwide Inc. (U.S.)
• Alva-Amco Pharmaceuticals Companies, Inc. (U.S.)
• HRA Pharma S.A. (France)

Browse Detail Summary For the Foot Care Products Market:

https://www.fortunebusinessinsights.com/foot-care-products-market-104272

Decreased Usage of Foots Inserts and Insoles During COVID-19 Hindered Market Growth

The COVID-19 outbreak negatively influenced the foot care products market growth due to the introduction of travel & trade restrictions, and enforcement of social distancing norms. Companies selling foot care products, including brands that sold smart shoes, had to shut down their operations to comply with the social distancing guidelines. This factor decreased the sales and usage of foot insoles and inserts and further slowed the market growth.

Segmentation: